Matthew Paulo
About Matthew Paulo
Matthew Paulo is a Manager at Bristol Myers Squibb, with a background in biomedical engineering and engineering management, and extensive experience in biopharmaceutical manufacturing and clinical research.
Company
Matthew Paulo currently works at Bristol Myers Squibb. He has held various positions within this organization, reflecting his progression and the depth of his experience within the company. His tenure at Bristol Myers Squibb includes roles such as Manager, MSAT MES, Sr. Specialist, Process Engineer 2, and Process Engineer 1.
Title
As the Manager, MSAT MES at Bristol Myers Squibb, Matthew Paulo is responsible for overseeing specific technical operations within the MSAT MES division of the company. This role requires a comprehensive understanding of manufacturing science and technology, particularly within the context of the biopharmaceutical industry.
Education and Expertise
Matthew Paulo studied Engineering Management at the University of Nebraska-Lincoln, earning a Master of Engineering (MEng). He also holds a Bachelor's degree in Biomedical/Medical Engineering from The College of New Jersey. His academic background equips him with a robust foundation in both managerial and technical aspects of engineering.
Background
Matthew Paulo began his professional journey as a Hem/Onc Clinical Research and Development Intern and I&I Clinical R&D and Medical Affairs Intern at Celgene, which provided him insight into clinical research. He then transitioned to a Manufacturing Associate role in CAR T at Celgene. His earlier work experience includes working as a lifeguard at Imperial Pool Management.
Experience in Biopharmaceutical Industry
Matthew Paulo has experience in clinical research and manufacturing within the biopharmaceutical industry. At Celgene, his roles ranged from research and development to manufacturing, providing him a well-rounded understanding of the industry. At Bristol Myers Squibb, he advanced to roles focused on process engineering and technical operations, further solidifying his expertise in biopharmaceutical manufacturing processes.